Back to ACAD
Ikarian Capital, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$7.1M
Q3 2026
Peak value
$17.1M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $625K |
| Q2 2026 | $711K |
| Q3 2026 | $2.3M |
| Q3 2026 | $17.1M |
| Q3 2026 | $7.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.1M | 350.0K | — | — |
| Q3 2026 | $17.1M | 850.0K | — | — |
| Q3 2026 | $2.3M | 112.0K | — | — |
| Q2 2026 | $711K | 28.1K | — | — |
| Q1 2026 | $625K | 28.1K | — | — |
Other funds holding ACAD
$954.9M
$864.7M
$386.3M
$383.2M
$377M
$323.1M